IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Clinical trial NCT07361874 · RECRUITING

Trial details

NCT number: NCT07361874
Sponsor: University of Texas Southwestern Medical Center
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Mild Autonomous Cortisol Secretion (MACS)Autonomous Cortisol Secretion (ACS)Subclinical Cushing's Mild Autonomous Cortisol Excess

Start date: 2026-03-05
Primary completion: 2030-05-31
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.